The effect of coenzyme Q10 on the regeneration of crushed facial nerve

J Craniofac Surg. 2015 Jan;26(1):277-80. doi: 10.1097/SCS.0000000000001201.

Abstract

Objective: The aim of this study is to show the possible positive effect of coenzyme Q10 (Co Q10) on regenerating in facial palsy.

Materials and methods: Sixteen female Sprague-Dawley albino rats were randomly divided into 2 groups as Co Q10 and control groups. Group Q10 (n = 8) received Co Q10 of 10 mg/kg/d intraperitoneally for 30 days, and group C (n = 8) received saline solution of 1 mL/d intraperitoneally once daily for 30 days. The right facial nerve stimulation thresholds were determined before crush, immediately after crush, and after 1 month.After determination of the thresholds, the crushed part of the facial nerve was then excised. All specimens were examined by a pathologist using a light microscope.

Results: No statistically significant difference in stimulation threshold was found between the Co Q10 and saline groups after crushing (P = 0.645). After 1 month of treatment, stimulation thresholds were significantly lower in both the Co Q10 and saline groups (Ps = 0.028 and 0.016). However, the Co Q10 group showed greater improvement than the saline group (P = 0.050).After 1 month of treatment, neither the Co Q10 group nor the saline group had reached the precrushing amplitude levels (Ps = 0.027 and 0.011).Significant differences were found in vascular congestion, macrovacuolization, and myelin thickness between the Co Q10 and control groups by light microscopy (P < 0.05).

Conclusions: Although many treatment methods have been tried to accelerate facial nerve regeneration after trauma, a definitive method has not been found yet. Co Q for the treatment of acute facial paralysis is promising on both physiologic assessments and pathologic evaluation.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Electric Stimulation
  • Electron Transport Chain Complex Proteins / therapeutic use
  • Facial Nerve Injuries / drug therapy*
  • Facial Nerve Injuries / pathology
  • Facial Nerve Injuries / physiopathology
  • Facial Paralysis / drug therapy
  • Facial Paralysis / physiopathology
  • Female
  • Hyperemia / drug therapy
  • Hyperemia / pathology
  • Myelin Sheath / drug effects
  • Myelin Sheath / pathology
  • Nerve Regeneration / drug effects*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Sensory Thresholds / drug effects
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / therapeutic use
  • Vacuoles / drug effects

Substances

  • Antioxidants
  • Electron Transport Chain Complex Proteins
  • Ubiquinone
  • coenzyme Q10